Guillaume Piessen

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer

Ronan J. Kelly, Jaffer A. Ajani, Thomas Zander et al. · New England Journal of Medicine · 2021 · 1.6K citations · Full text

Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Florian Lordick, Fátima Carneiro, Stefano Cascinu et al. · Annals of Oncology · 2022 · 1.2K citations · Full text

Esophagus, Gastrointestinal Oncology, Medicine +7

Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer

C. Mariette, Sheraz R. Markar, Tienhan Sandrine Dabakuyo‐Yonli et al. · New England Journal of Medicine · 2019 · 695 citations

Effect of Interval (7 or 11 weeks) Between Neoadjuvant Radiochemotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized, Controlled Trial (GRECCAR-6)

Jérémie H. Lefèvre, Laurent Mineur, Salma Kotti et al. · Journal of Clinical Oncology · 2016 · 462 citations

Rectal Tumor, Surgical Oncology, Health Sciences +15

The Number of Metastatic Lymph Nodes and the Ratio Between Metastatic and Examined Lymph Nodes Are Independent Prognostic Factors in Esophageal Cancer Regardless of Neoadjuvant Chemoradiation or Lymphadenectomy Extent

C. Mariette, Guillaume Piessen, Nicolas Briez et al. · Annals of Surgery · 2008 · 401 citations